Syschem (India)
SYSCHEMBSE

Syschem (India)

₹46.800.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
46.50
Today’s high
48.50
52 week low
40.50
52 week high
62.00
Open price
47.24
Previous close
46.80
Live volume
--
Lower circuit
37.44
Upper circuit
56.16

Fundamentals

Market Cap
₹229Cr
ROE
8.93%
P/E Ratio(TTM)
20.99
EPS(TTM)
2.23
P/B Ratio
1.87
Dividend Yield
0.00%
Industry P/E
44.85
Book Value
24.98
Debt to Equity
0.00
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹248
+53.61%
Profit (Cr)
₹1.74
-58.27%
025100225400
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+79%
3Y CAGR+80%
Profit growthValue
1Y (TTM)+278%
3Y CAGR+31%

About

Established in 1993, Syschem India Limited operates in the pharmaceutical sector by producing Active Pharmaceutical Ingredients (APIs) and bulk drugs for the healthcare industry. Its guiding principle is to achieve business excellence and focus on creating long-term shareholder value while considering the needs of all its stakeholders. The company utilizes lean manufacturing processes to maintain stable profit margins and ensure high-quality products that are well-accepted in the market. Key products manufactured include Amoxycillin Trihydrate and Ampicillin Trihydrate, forming a crucial part of its single-segment pharma business operations. A key expansion plan involves setting up a new plant which is currently in process and will soon start generating revenue to meet market demand. The company has successfully turned profitable, showcasing its ability to grow with a management approach focused on converting past losses into profits.;
CEO/MD
Mr. Ranjan Jain
Founded in
1993
BSE symbol
531173

Shareholding Pattern

Apr '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
60.86%
Retail And Others
38.97%
Other Domestic Institutions
0.16%
Livesquawk
Syschem (India) plans to expand its manufacturing unit with a 140M INR investment.
Livesquawk
Syschem India Ltd begins commercial production of a 600 MT Cloxacillin unit. The company expanded its 1200 MT Amoxicillin unit starting January 5, 2026.
2026
25
May
Quarterly & Annual Result
Release date
2
Feb
Quarterly Result
Release date
2025
10
Nov
Quarterly Result
Release date
4
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks